Catabasis Pharmaceuticals Inc (CATB) Actualités

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 23, 2023 4:30...

Quarterly Report (10-q)

10001454789--12-312023Q1falseNon-accelerated Filer00275013402798671831455311070001454789atxs:JefferiesMemberatxs:AtMarketOfferingMember2022-11-0120...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...

Current Report Filing (8-k)

0001454789 false 0001454789 2023-03-27 2023-03-27 iso4217:USD xbrli:shares...